Zusammenfassung
Seit seiner Entdeckung im Jahr 1879 durch Paul Ehrlich fasziniert und inspiriert der eosinophile Granulozyt Ärzte wie Wissenschaftler. In den letzten Jahren ist mit der Verfügbarkeit von Interleukin-5-Blockern das Interesse noch weiter gestiegen. Während die Zelle bei physiologischen Prozessen keine Rolle spielt, kommt ihr im Rahmen bestimmter infektiöser oder immunologischer Prozesse eine zentrale Bedeutung zu. Einerseits ist der Eosinophile bei der angeborenen Immunantwort gegen bestimmte Pathogene beteiligt, insbesondere bei Parasitosen. Auf der anderen Seite induziert die Zelle bei anderen Erkrankungen über die Freisetzung basischer Granulaproteine und reaktiver Sauerstoffspezies eine lokale Entzündung mit Nekrose des infiltrierten Gewebes. Darüber hinaus sind Eosinophile an der lokalen Gewebehomöostase und an der Modulation erworbener Immunreaktionen über Bildung und Freisetzung von verschiedensten Lipidmediatoren, Chemokinen, Zytokinen und Wachstumsfaktoren beteiligt. Diese Übersicht stellt die Morphologie, Zellbestandteile, Oberflächenantigene und Effektormechanismen der Eosinophilen in Bezug zu ihrer pathogenetischen Bedeutung im Rahmen von Eosinophilen-assoziierten Erkrankungen dar.
Abstract
Ever since its discovery in 1879 by Paul Ehrlich the eosinophil has fascinated and inspired clinicians and scientists alike. In recent years, interest in eosinophils has dramatically increased with the availability of interleukin-5 blockers. Although eosinophils do not seem to play an essential role in physiological processes, their numbers are markedly raised in certain pathological conditions, such as certain infectious and immunological diseases. Functionally, eosinophils play a role in the innate host defence against pathogens, particularly parasites. On the other hand, the cells may damage both pathogens and host cells through the release of basic granule proteins and reactive oxygen species. In addition, eosinophils are involved in local tissue homeostasis and modulation of adaptive immune responses through the production and release of various lipid mediators, chemokines, cytokines, and growth factors. This review summarizes the cell morphology and components, surface antigens, as well as effector mechanisms of eosinophils with respect to their pathogenic significance in eosinophil-related diseases.
Abbreviations
- CCL:
-
CC-Chemokinligand
- CCR:
-
CC-Chemokinrezeptor
- CXCL:
-
CXC-Chemokinligand
- CXCR:
-
CXC-Chemokinrezeptor
- ECP:
-
„Eosinophil cationic protein“
- EDN:
-
„Eosinophil-derived neurotoxin“
- EE:
-
Eosinophile Ösophagitis
- EGID:
-
Eosinophilenassoziierte gastrointestinale Erkrankung
- EGPA:
-
Eosinophile Granulomatose mit Polyangiitis
- EPO:
-
Eosinophile Peroxidase
- GM-CSF:
-
„Granulocyte-macrophage colony-stimulating factor“
- IL:
-
Interleukin
- MBP:
-
„Major basic protein“
- PAF:
-
„Platelet-activating factor“
- PG:
-
Prostaglandine
- SCF:
-
„Stem cell factor“
- TGF:
-
„Transforming growth factor“
- TNF:
-
„Tumor necrosis factor“
- Tx:
-
Thromboxan
Literatur
Acharya KR, Ackermann SJ (2014) Eosinophil granule proteins: form and function. J Biol Chem 289:17406–17415
Chen YY, Khoury P, Ware JM, Holland-Thomas NC, Stoddard JL, Gurprasad S, Waldner AJ, Klion AD (2014) Marked and persistent eosinophilia in the absence of clinical manifestations. J Allergy Clin Immunol 133:1195–1202
Chu VT et al (2011) Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat Immunol 12:151–159
Davoine F, Lacy P (2014) Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity. Front Immunol. Acta Neurochir (Wien) 5:570
Ehrlich P (1879) Ueber die spezifischen Granulationen des Blutes. Archiv für Anatomie und Physiologie. Physiologische Abteilung, S 571–579
Fukuda T, Fukushima Y, Numao T, Ando N et al (1996) Role of interleukin-4 and vascular cell adhesion molecule-1 in selective eosinophil migration into the airways in allergic asthma. Am J Respir Cell Mol Biol 14:84–94
Furuta GT et al (2005) Eosinophils alter colonic epithelial barrier function: role for major basic protein. Am J Physiol Gastrointest Liver Physiol 289:G890–G897. [PubMed: 16227527]
Fulkerson P, Rothenberg M (2013) Targeting eosinophils in allergy, inflammation and beyond. Nat Rev Drug Discov 12:117–129
Gleich GJ, Adolphson CR (1986) The eosinophilic leukocyte: structure and function. Adv Immunol 39:177–253
Gleich GJ (2013) Historical overview and perspective on the role of the eosinophil in health and disease. In: Lee JJ, Rosenburg HF (Hrsg) Eosinophils in Health and Disease. Academic Press, Waltham, Mass, USA, S 1–12
Gouon-Evans V, Rothenberg ME, Pollard JW (2000) Postnatal mammary gland development requires macrophages and eosinophils. Development 127:2269–2282
Hastie AT, Moore WC, Li H, Rector BM et al (2013) Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects. J Allergy Clin Immunol 132:72–80
Hogan SP, Rosenberg HF, Moqbel R et al (2008) Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 38:709–750
Humbles A, Lloyd C, McMillan S, Friend D et al (2004) A critical role for eosinophils in allergic airways remodeling. Science 305:1776–1779
Kargili A, Bavbek N, Kaya A, Koşar A, Karaaslan Y (2004) Eosinophilia in rheumatologic diseases: a prospective study of 1000 cases. Rheumatol Int 24:321–324
Kay A (2014) The early history of the eosinophil. Clin Exper Allergy. Acta Neurochir (Wien) 45:575:582
Khoury P, Grayson PC, Klion AD (2014) Eosinophils in vasculitis: characteristics and roles in pathogenesis. Nat Rev Rheumatol 10:474–483
Eosinophils KH (2013) multifunctional and distinctive properties. Int Arch Allergy Immunol 161(Suppl 2):3–9
Kroegel C, Dewer A, Yukawa T et al (1993) Ultrstructural characterization of platelet-stimulated human eosinophils from patients with asthma. Clin Sci 84:391–399
Kroegel C, Luttmann W, Zeck-Kapp G et al (1994) Zellbiologie und Funktion des eosinophilen Granulozyten im Rahmen der immunologischen Entzündung. Immun Infekt 22:104–113
Kroegel C (2014) Costabel U. Klinische Pneumologie. Das Referenzwerk für Klinik und Praxis. Thieme, Stuttgart
Kroegel C, Foerster M, Seeliger B, Slevogt H, Costabel U, Neumann T (2017) Eosinophile Granulomatose und Polyangiitis (EGPA, Churg-Strauss-Syndrom) - Pathogenetische und klinische Grundlagen, Diagnostik und Behandlungszugänge. Arzneimitteltherapie 35:413–426
Kroegel C, Foerster M, Quickert S, Slevogt H, Neumann T (2018) Vaskulitiden und eosinophile Lungenerkrankungen. Pneumologe 15:55–71
Lewis R, Soter N, Diamond P et al (1982) Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol 129:1627–1631
Luijk B, Lindemans C, Kanters D, van der Heijde R et al (2005) Gradual increase in priming of human eosinophils during extravasation from peripheral blood to the airways in response to allergen challenge. J Allergy Clin Immunol 115:997–1003
Marzano AV, Tedeschi A, Rossio R, Fanoni D, Cugno M (2010) Prothrombotic state in Churg-Strauss syndrome: a case report. J Investig Allergol Clin Immunol 20:616–619
Mesquita-Santos F, Vieira-de-Abreu A, Calheiros A et al (2006) Cutting edge: prostaglandin D2 enhances leukotriene C4 synthesis by eosinophils during allergic inflammation: synergistic in vivo role of endogenous eotaxin. J Immunol 176:1326–1330
Mishra A, Hogan SP, Lee JJ, Foster PS, Rothenberg ME (1999) Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J Clin Invest 103:1719–1727
Mutalithas K, Guillen C, Day C, Brightling C Pavord I, Wardlaw A (2010) CRTH2 expression on T cells in asthma. Clin Exp Immunol 161:34–40
Navarro S, Aleu J, Jimenez M, Boix E, Cuchillo C, Nogues M (2008) The cytotoxicity of eosinophil cationic protein/ribonuclease 3 on eukaryotic cell lines takes place through its aggregation on the cell membrane. Cell Mol Life Sci 65:324–337
McNagny K, Graf T (2002) Making eosinophils through subtle shifts in transcription factor expression. J Exp Med 195:F43–F47. PMC:2193544M
Minshall EM, Leung DY, Martin RJ et al (1997) Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 17(3):326–333
Patel K (1989) Eosinophil tethering to interleukin-4-activated endothelial cells requires both P‑selectin and vascular cell adhesion molecule-1. Blood 92:3904–3911
Roufosse FE, Kahn JE, Gleich GJ et al (2013) Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes. J Allergy Clin Immunol 131:461-7:e1–5
Robertson SA, Mau VJ, Hudson SN, Tremellen KP (1997) Cytokine-leukocyte networks and the establishment of pregnancy. Am J Reprod Immunol 37:438–442
Rothenberg ME, Hogan SP (2006) The Eosinophil. Annu Rev Immunol 24:147–174
Rothenberg ME, Klion AD, Roufosse FE, Kahn JE, Weller PF, Simon HU et al (2008) Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med 358:1215–1228
Samter M (1980) Eosinophils: the first 90 years. In: Mahmoud AAF, Austen KF (Hrsg) The Eosinophil in Health and Disease. Grune and Stratton, New York, S 25–43
Smit J, Lukacs N (2006) A closer look at chemokines and their role in asthmatic responses. Eur J Pharmacol 533:277–288
Spector SL, Tan RA (2012) Is a single blood eosinophil count a reliable marker for “eosinophilic asthma?”. J Asthma 49:807–810
Spencer LA, Bonjour K, Melo RC, Weller PF (2014) Oct 27;5:496. Eosinophil secretion of granule-derived cytokines. Front Immunol, Bd. 2014. https://doi.org/10.3389/fimmu.2014.00496
Eosinophils SCJF (1988) A Comprehensive Review and Guide to the Scientific and Medical Literature. Oxford. Oxford Medical, Publications
Symon F, Lawrence M, Williamson M, Walsh G, Watson S, Wardlaw A (1996) Functional and structural characterization of the eosinophil P‑selectin ligand. J Immunol 157:1711–1719
Szefler SJ, Wenzel S, Brown R et al (2012) Asthma outcomes: biomarkers. J Allergy Clin Immunol 129(3 Suppl):S9–S23
Varricchi G, Bagnasco D, Borriello F, Heffler E, Canonica GW (2016) Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs. Curr Opin Allergy Clin Immunol 16:186–200
Walsh JC et al (2002) Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates. Immunity 17:665–676
Wardlaw AJ (1999) Molecular basis for selective eosinophil trafficking in asthma: a mulitstep paradigm. J Allergy Clin Immunol 104:917–926
Winkel P, Statland BE, Saunders AM, Osborn H, Kupperman H (1981) Within-day physiologic variation of leukocyte types in healthy subjects as assayed by two automated leukocyte differential analyzers. Am J Clin Pathol 75:693–700
Yousefi S, Hemmann S, Weber M et al (1995) IL-8 is expressed by human peripheral blood eosinophils. Evidence for increased secretion in asthma. J Immunol 154:5481–5490
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
C. Kroegel, M. Foerster, A. Moeser, H. Slevogt und U. Costabel geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Additional information
Redaktion
J. Schreiber, Magdeburg
C. Kroegel, Jena
Rights and permissions
About this article
Cite this article
Kroegel, C., Foerster, M., Moeser, A. et al. Eosinophile Granulozyten. Pneumologe 15, 299–308 (2018). https://doi.org/10.1007/s10405-018-0202-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10405-018-0202-x